Search results
Found 18026 matches for
Risk of Death Doubled in Patients with Chronic Disease and Co-occurring Psychiatric Disorders
27 January 2022
A new study led by Professor Seena Fazel at the University of Oxford found that among patients with chronic, non-communicable diseases, the risk of death is more than doubled if they also have a psychiatric disease.
Ethics in Mental Health Digital Innovations for Young People in Africa: Digital Campaign
27 January 2022
This campaign was led by a team of 29 Early Career Researchers (ECRs) and a Young People's Advisory Group (YPAG) across five African countries. The young people wanted to share contextual and accessible information on digital mental health and ethical issues that are important to them.
New Review Shows Improved Transparency in Antidepressant Drug Trials
20 January 2022
A new review and meta-analysis, published today in the journal PLOS Medicine, indicates that drug companies conducting clinical trials on new antidepressants have increased disclosure of clinical trials with negative outcomes, that is, trials that fail to show the drug is more effective than a placebo.
How Mindfulness May Improve Body Satisfaction and Mood
20 January 2022
New research from Emma Osborne, Research Assistant at the Centre for Research on Eating Disorders (CREDO) at the University of Oxford (and PhD Candidate at the University of Bath), and Dr Melissa Atkinson, University of Bath, investigated two ways in which mindfulness might improve body satisfaction and mood.
Review Highlights Risk Factors Associated with Violence in Schizophrenia
20 January 2022
Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).
New Study will Investigate Brain Fog Symptoms in Post-Hospitalised COVID-19 Patients
17 January 2022
C-Fog is a collaborative new study led by Oxford University researcher, Dr Maxime Taquet, which will investigate the reasons why brain fog or cognition problems affect patients after COVID-19 infection. With a better understanding of the mechanisms involved it may be possible to understand how to treat brain fog and help many thousands of people worldwide.
A New Experimental Study Investigated the Effects of Atorvastatin on Emotional Processing
10 January 2022
Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.
Joy - Exhibition at the Wellcome Collection: until 27 February 2022
20 December 2021
Morten Kringelbach, Professor of Neuroscience, University of Oxford, contributed expert insight about the relationship between pleasure and emotional and physical health in the context of artwork in the current Joy Exhibition.
People with Long-COVID After Hospitalisation Face Limited Recovery After One Year
16 December 2021
People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients.
The Effects of Social Media on Public Attention and Attitudes Towards COVID-19 Vaccines in the UK
14 December 2021
A new study finds that media coverage of positive vaccine research can have a positive effect on overall social media sentiment, countering vaccine misinformation, but the effects wane over time.
Should Children be Offered Vaccination against COVID-19?
13 December 2021
New Rapid Ethics Review from the UK Pandemic Ethics Accelerator investigates the question of whether or not children should be offered vaccination against COVID-19, a question which has raised significant ethical challenges.
New Clinical Trial to Test Drug for Diabetes in Reducing Risk of Alzheimer’s Dementia
10 December 2021
A new study led through a collaboration between the Diabetes Trials Unit and the Department of Psychiatry at the University of Oxford, and the global healthcare company, Novo Nordisk, will examine whether semaglutide, a tablet used to treat diabetes, can change the course of the earliest changes that happen in the brains of people at risk of developing Alzheimer’s dementia.
New Professors in the Department of Psychiatry
9 December 2021
Professors Mina Fazel, Morten Kringelbach and Mike Browning have been given the title of Professor in the 2021 Recognition of Distinction Exercise at the University of Oxford.
The History of Autism
9 December 2021
New research published by David Sher, DPhil student in the Department of Psychiatry, and Associate Professor Jenny Gibson, University of Cambridge, delves into the work of Russian psychiatrist GE Sukhareva.
Mindfulness for Teachers - "Finding Peace in a Frantic World"
30 November 2021
A new research study involving more than 200 teachers from across the UK investigated how their experiences and levels of stress, mental health and burn out were impacted by either taught or self-taught mindfulness training.
New Research Highlights Importance of Early Years Development on Future Wellbeing
25 November 2021
Oxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.
2021 Most Highly Cited Researchers
16 November 2021
Four researchers in the Department of Psychiatry are in the Highly Cited Researcher 2021 list.
Oxfordshire Young People Involved in Childline Research Project
4 November 2021
New research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People’s Advisory Group in the Department of Psychiatry at the University of Oxford, and the NSPCC, has looked at how Childline’s message boards help support young people.
28th British Isles Research Workshop on Suicide and Self-Harm & Lancet Psychiatry Suicide Symposium
2 November 2021
This year's annual meeting focused again on research related to the impact of the COVID-19 pandemic on suicide and self-harm. There was another session on online safety in the context of suicidal behaviour and the Online Safety Bill. Organised by the Centre for Suicide Research, University of Oxford, these virtual workshops for both senior and early career researchers from the UK and Ireland provide an important opportunity to share knowledge and discuss the latest research. This year there were also contributions from Australia and Denmark.
Experimental Medicine and Industry Partnership
1 November 2021
The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.